Insider · CIK 0001533175
Joel Becker
Files at NPCE (NeuroPace Inc). First filing -, latest -.
In brief
Joel Becker files SEC Form 4 as CEO and director at NPCE (NeuroPace Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joel Becker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,310 | $14.75 | $19k | 138,000 | 40 d ago |
| Aug 27, 2026 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,126 | $14.13 | $16k | 139,310 | Aug 28, 2026 |
| Jun 3, 2026 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,255 | $15.88 | $20k | 140,436 | Jun 4, 2026 |
| May 27, 2026 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,126 | $17.06 | $19k | 141,691 | May 28, 2026 |
| May 15, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +45,880 | $0.00 | $0 | 142,817 | May 19, 2026 |
| May 15, 2026 | NPCE NeuroPace Inc | AGrant or award Stock Option (Right to Buy)derivative | +122,190 | $0.00 | $0 | 122,190 | May 19, 2026 |
| Mar 3, 2026 | NPCE NeuroPace Inc | FTax withholding Common Stock | -5,023 | $13.83 | $69k | 96,937 | Mar 4, 2026 |
| Feb 27, 2026 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,126 | $14.58 | $16k | 101,960 | Mar 2, 2026 |
| Nov 27, 2025 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,126 | $16.50 | $19k | 103,086 | Dec 1, 2025 |
| Aug 27, 2025 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,126 | $8.88 | $9,999 | 104,212 | Aug 28, 2025 |
| May 27, 2025 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,126 | $12.66 | $14k | 105,338 | May 29, 2025 |
| Feb 27, 2025 | NPCE NeuroPace Inc | FTax withholding Common Stock | -4,506 | $12.56 | $57k | 47,964 | Mar 20, 2025 |
| Mar 10, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +58,500 | $0.00 | $0 | 106,464 | Mar 20, 2025 |
| Mar 10, 2025 | NPCE NeuroPace Inc | AGrant or award Stock Option (Rt to Buy)derivative | +99,200 | $0.00 | $0 | 99,200 | Mar 20, 2025 |
| Feb 27, 2024 | NPCE NeuroPace Inc | AGrant or award Common Stock | +52,470 | $0.00 | $0 | 52,470 | Feb 28, 2024 |
| Feb 27, 2024 | NPCE NeuroPace Inc | AGrant or award Stock Option (Right to Buy)derivative | +104,720 | $0.00 | $0 | 104,720 | Feb 28, 2024 |
Questions about Joel Becker
Answered from the filings on this page, as of the latest one.
Is Joel Becker buying or selling?
Joel Becker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joel Becker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joel Becker has 0.
Where does Joel Becker file Form 4?
Joel Becker has filed Form 4 at NPCE (NeuroPace Inc) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.